Retractable Protein Nanoneedles The ability to control the transfer of molecules through cellular membranes is an important function in synthetic biology; a new study from researchers at Harvard’s Wyss Institute for Biologically Inspired Engineering and Harvard Medical School (HMS) introduces a novel mechanical method for controlling release of molecules inside cells.Advancing Synthetic Biology Living systems rely on a dizzying variety of chemical reactions essential to development and survival. Most of these involve a specialized class of protein molecules — the enzymes.NIH Researchers Identify Striking Genomic Signature for Cancer Institute has identified striking signature shared by five types of cancer.CRI Develops Innovative Approach for Identifying Lung Cancer Institute has developed innovative approach for identifying processes that fuel tumor growth in lung cancer patients.Counting Cancer-busting Oxygen Molecules Researchers from the Centre for Nanoscale BioPhotonics (CNBP), an Australian Research Centre of Excellence, have shown that nanoparticles used in combination with X-rays, are a viable method for killing cancer cells deep within the living body.Crowdfunding the Fight Against Cancer From budding social causes to groundbreaking businesses to the next big band, crowdfunding has helped connect countless worthy projects with like-minded people willing to support their efforts, even in small ways. But could crowdfunding help fight cancer?
Cancer Cells Kill Off Healthy Neighbours Cancer cells create space to grow by killing off surrounding healthy cells, according to UK researchers working with fruit flies.Cancer Drug Target Visualized at Atomic Resolution New study using cryo-electron microscopy shows how potential drugs could inhibit cancer.Genetic Mechanism Behind Cancer-Causing Mutations Researchers at Indiana University has identified a genetic mechanism that is likely to drive mutations that can lead to cancer.Future of Medicine Could be Found in a Tiny Crystal Ball A Drexel University materials scientist has discovered a way to grow a crystal ball in a lab. Not the kind that soothsayers use to predict the future, but a microscopic version that could be used to encapsulate medication in a way that would allow it to deliver its curative payload more effectively inside the body.
The Bru-seq Technology Platform for Nascent RNA analysis Mats Ljungman, Professor, University of Michigan will present a set of novel techniques to analyze many aspects of gene expression based on the capturing of nascent RNA.
Translation of Omic Data into Personalised Oncology Tools The Challenge and the Reward William Gallagher, University College Dublin, speaking at Diagnostics & Biomarkers 2015.
Plasma Vitronectin Predicts Response to Fluoropyrimidine-oxaliplatin (FOLFOX) Chemotherapy in Metastatic Colorectal Cancer Sarah Hayes, University of Sydney, speaking at Diagnostics & Biomarkers 2015.
Drug Sensitivity and Resistance Testing Platform for Personalized Medicine at the Institute for Molecular Medicine Finland (FIMM) Jani Saarela, Institute for Molecular Medicine, speaking at Screening Europe 2015
Oncology Biomarker Testing Current US Practice Baseline and Emerging Trends Julia Trosman, Center for Business Models in Healthcare, speaking at Diagnostics & Biomarkers 2015.
Novel Chip-based Extraction of miRNA Gregory Dame, University of Freiburg, speaking at Point of Care Diagnostics 2015
Imaging Biomarkers - Future or Reality Edwin van Beek, University of Edinburgh, speaking at Diagnostics & Biomarkers 2015.
Discovery of Potent and Selective Inhibitors of Monopolar Spindle 1 (MPS1) Kinase Rob van Montfort, The Institute of Cancer Research, speaking at Discovery Chemistry Congress 2015.
Fit-for-Purpose Biomarker Assay Validation - From Research Tool to Diagnostic Test Jeff Cummings, Cancer Research UK, speaking at Diagnostics & Biomarkers 2015.
Biomarkers to Predict Aggressive Prostate Cancer Claire Morgan, Swansea University, speaking at Diagnostics & Biomarkers 2015.